Navigation Links
Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients
Date:1/8/2012

progression during Avastin® treatment, implying that combination therapy with VGX-100 and Avastin® could significantly improve treatment outcomes in cancer patients.

Circadian's wholly owned subsidiary, Vegenics Pty Ltd, owns worldwide rights to an extensive intellectual property portfolio covering the angiogenesis and lymphangiogenesis targets VEGF-C, VEGF- D and the receptor protein VEGFR-3.  Vegenics has also been granted exclusive worldwide rights to intellectual property filed by Schepens Eye Research Institute covering the use of anti-lymphangiogenic molecules for the treatment of Dry Eye Disease.Company Enquiries:

Media Enquiries – International:  

 Robert Klupacs

Lauren Glaser Managing Director - Circadian

The Trout Group LLC Tel: +61 (0) 3 9826 0399 or

251 Post Street, Suite 412 robert.klupacs@circadian.com.au 

San Francisco, CA 94108  

Tel +1 215 740 8468  

lglaser@troutgroup.comAbout Circadian Technologies LimitedCircadian (ASX:CIR; OTCQX:CKDXY) is a biologics drug developer focusing on cancer and 'front of the eye' disease therapies.  It controls exclusive worldwide rights to a significant intellectual property portfolio around Vascular Endothelial Growth  Factor  (VEGF)-C and -D. The  applications for the  VEGF technology,  which functions in regulating blood and lymphatic vessel growth, are substantial  and broad. Circadian's internal product development programs are primarily focussed on  developing  VGX-100 (a human antibody against  VEGF-C) as a treatment for solid tumours, in particular glioblastoma and colorectal cancer, as well as for 'front of the eye' disease such as corneal neovascularisation and/or corneal allograft rejection.  Circadian has also licensed
'/>"/>

SOURCE Circadian Technologies Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Circadiance Launches Revolutionary New CPAP Tube
2. Circadian Receives FDA IND Approval to Begin Clinical Trials With VGX-100 for the Treatment of Cancer Patients With Solid Tumors
3. Circadian Files IND With FDA for VGX-100 for the Treatment of Cancer Patients With Solid Tumors
4. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
5. Ikaria® Commences Global Registration Trial for Bioabsorbable Cardiac Matrix
6. Coronado Biosciences Commences Public Trading on the OTC Bulletin Board
7. Hotspur Technologies Commences US Launch at Veith/AIM Conference in New York City
8. CryoLife Commences Tender Offer for All Outstanding Shares of Cardiogenesis Corporation
9. Unilife Commences Initial Production of Unifill Prefilled Syringe
10. Quest Diagnostics Commences Tender Offer for Acquisition of Celera
11. Milestone Scientific Inc. Commences Trading on the OTC Pink
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... HOUSTON , Oct. 22, 2014  Charlene Vernak, RPh, ... York , recently was awarded the George Roentsch ... Vernak received the award in Houston ... The scholarship is awarded annually to an independent pharmacist ... nature of George Roentsch , a well-known pharmacist ...
(Date:10/22/2014)... SAN DIEGO , Oct. 22, 2014 ... II medical device received 510 (k) OTC clearance by ... the AVACEN 100 to be marketed over the Internet ... with arthritis; muscle spasms; and minor strains and sprains ... The AVACEN 100 (MSRP $2495) is a ...
(Date:10/22/2014)... Oramed Pharmaceuticals Inc. (NASDAQCM: ... company focused on the development of oral drug ... from its Phase IIa clinical trial of ORMD-0801, ... type 1 diabetes. The trial was conducted in ... U.S. Food and Drug Administration (FDA) Investigational New ...
Breaking Medicine Technology:PCCA Awards Charlene Vernak, RPh, the George Roentsch Scholarship 2AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4
(Date:10/22/2014)... Healthcare professionals who are looking ... at home or on-the-go via laptops, tablets or ... new, premium Seminar-on-Demand CE courses. The new courses ... 2,000 hours of CE course offerings, allowing ... With such a diverse library, there’s something for ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Although there are only ... time for many people who have trouble finding time within their ... to exercise for long periods of time to get in shape. ... goals while on the go. , Change Up Your Commute ... to work to add some exercise into your daily routine. If ...
(Date:10/22/2014)... PA (PRWEB) October 22, 2014 Richard ... as an industry leader with over 25 years experience. ... team leader in the areas related to EDI, B2B ... Carlson is an Editorial Advisory Board member for Pharmaceutical ... Educator. Blue Fin Group is a management and ...
(Date:10/22/2014)... Steven Reinberg HealthDay Reporter , ... add weight and length may be showing a genetic propensity ... adults, certain genes have been linked to increased body fat, ... fat and lean muscle, the researchers said. At 1 ... By ages 2 and 3, however, these genes were linked ...
(Date:10/22/2014)... sisters in high school have developed ways to measure ... use electronic stethoscopes, which electronically amplify body sounds, to ... heartbeats. Ilina, a senior at Port Huron Northern ... to detect early lung damage in people exposed to ... one breath cycle each from 16 smokers, 25 nonsmokers ...
Breaking Medicine News(10 mins):Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2
... earlier research involving hormone therapy , , WEDNESDAY, April ... therapy appear to have a 28 percent reduction in ... found. , But researchers don,t yet know why the ... women remains the same: Take hormone replacement therapy at ...
... young baseball playersROSEMONT, Ill., April 22 For generations, baseball ... for kids to get some exercise along with their first ... of Orthopaedic Surgeons ( http://www.aaos.org ) (AAOS) urges ... , ...
... celebritiesParis Hilton, Nicole Ritchie, Michelle Rodriguez and Lindsay Lohanyielded ... any public health context, according to a new report ... Public Health,s Center for Injury Research and Policy. Analyzing ... and the evening news broadcasts from ABC, NBC, CBS, ...
... heavier people produces more greenhouse gases, researchers say , , ... does more than protect your health. It also ... London School of Hygiene & Tropical Medicine say that ... gases, a lean population, such as in Vietnam, consumes ...
... Newly established CandleInTheWindow.org announces a $1,000 scholarship/award for ... pregnant women in need that the bearer of the symbol ... to get beyond the labels of Pro-life and Pro-choice and ... Everyneighborhood, USA there are hundreds of people right ...
... School of Medicine and the Moores UCSD Cancer Center have ... to be part of the first line of defense against ... found that when these cells, known as lymphocytes, make an ... likely to spread to the lungs. , They have ...
Cached Medicine News:Health News:HRT May Protect Women From Colon Cancer 2Health News:Swing That Bat Into Baseball Season, Injury Free 2Health News:Swing That Bat Into Baseball Season, Injury Free 3Health News:Media ignores health consequences of drinking and driving among young celebrities 2Health News:Staying Slim Is Good for the Environment 2Health News:$1000 Scholarship/Award for Best Poster/Ribbon Design That Encourages Needy Pregnant Women to Ask Bearers for Help 2Health News:Instead of fighting breast cancer, immune cell promotes its spread 2
... III Model 8042 increases therapy versatility ... to optimize sensing, pacing and cardiac ... offers unmatched insight through key heart ... efficiently track a patient's clinical status. ...
... OTI-Scan 3D is the ... system available today. This ... and A-scan system operates ... desktop or laptop computer ...
... is an extremely accurate digital A-scan system. ... noise probe and fast precise algorithm enables ... probe along the visual axis. The A5500 ... CRT monitor, built-in thermal printer, 5 different ...
... Accurate, efficient and easy to use. The ... variety of regressive, theoretical, and adaptive IOL ... the patient. Convenient design features improve your ... hands-free operation, audible tone to minimize corneal ...
Medicine Products: